These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9866732)

  • 21. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea.
    Linhares AC; Lanata CF; Hausdorff WP; Gabbay YB; Black RE
    Pediatr Infect Dis J; 1999 Nov; 18(11):1001-6. PubMed ID: 10571438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public health considerations for the introduction of new rotavirus vaccines for infants: a case study of tetravalent rhesus rotavirus-based reassortant vaccine.
    Clemens J; Keckich N; Naficy A; Glass R; Rao M
    Epidemiol Rev; 1999; 21(1):24-42. PubMed ID: 10520471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M; Schödel F
    Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y; Kapikian AZ
    J Health Popul Nutr; 2000 Jun; 18(1):5-14. PubMed ID: 11014764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of a rotavirus vaccine. Field trials in Venezuela].
    Pérez Schael I; Rojas Mazzei AM; Flores J
    Acta Cient Venez; 1991; 42(6):296-312. PubMed ID: 1668865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis.
    Heaton PM; Goveia MG; Miller JM; Offit P; Clark HF
    J Infect Dis; 2005 Sep; 192 Suppl 1():S17-21. PubMed ID: 16088800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine.
    Santos N; Hoshino Y
    Rev Med Virol; 2005; 15(1):29-56. PubMed ID: 15484186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR
    J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The present status of rotavirus vaccine development.
    Bishop R
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):429-35. PubMed ID: 2851184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of rotavirus: Implications for child health.
    Bishop R
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S81-5. PubMed ID: 19799704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rotavirus infection in Brazil: epidemiology and challenges for its control].
    Linhares AC
    Cad Saude Publica; 2000; 16(3):629-46. PubMed ID: 11035503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.
    Grimwood K; Lambert SB; Milne RJ
    Paediatr Drugs; 2010 Aug; 12(4):235-56. PubMed ID: 20593908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotavirus surveillance--worldwide, 2001-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1255-7. PubMed ID: 19023263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity and correlates of protection for rotavirus vaccines.
    Franco MA; Angel J; Greenberg HB
    Vaccine; 2006 Apr; 24(15):2718-31. PubMed ID: 16446014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.